Status:

COMPLETED

Nicotine Patch Pretreatment for Smoking Cessation in PTSD

Lead Sponsor:

US Department of Veterans Affairs

Conditions:

Stress Disorders, Posttraumatic

Tobacco Use Disorder

Eligibility:

All Genders

18-70 years

Phase:

EARLY_PHASE1

Brief Summary

This study seeks to evaluate the relationship between PTSD, abstinence, and factors associated with relapse in the context of a randomized, clinical smoking cessation trial.

Detailed Description

Smokers with PTSD will be randomly assigned to 1 of 2 pre-cessation patch therapy conditions (active patch versus placebo patch) for three weeks before a target quit-smoking date. All participants to ...

Eligibility Criteria

Inclusion

  • Smokers who smoke 10 or more cigarettes per day in the past year;
  • 18-80 years old;
  • English speakers;
  • medically stable;
  • stable on current medication regimen

Exclusion

  • Pregnant women excluded;
  • participants with organic mental disorder, schizophrenia, bipolar disorder, lifetime but not current PTSD, current substance abuse or dependence;
  • medical conditions contraindicated with nicotine replacement therapy;
  • use other forms of nicotine (cigars, nicotine gum, etc.)

Key Trial Info

Start Date :

May 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2013

Estimated Enrollment :

87 Patients enrolled

Trial Details

Trial ID

NCT00625131

Start Date

May 1 2008

End Date

March 1 2013

Last Update

November 20 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VA Medical Center, Durham

Durham, North Carolina, United States, 27705